NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/26/2025
Back to search
Official data from USPTO
JYMED PEPTIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
05/20/2025
Trademark type
Combined
Nice classes
5, 35
Filing date
11/17/2015
Registration date
04/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/26/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/16/2014
First use in commerce
07/21/2016
Drawing code
5
Owner type
99
Owner location
Shenzhen,Pingshan Dist, CN
Examiner
GARCIA, CLAUDIA
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of stylized letters "JYMED PEPTIDE".
Holders and representatives
Holders
Shenzhen JYMed Technology Co., Ltd.
Shenzhen JYMed Technology Co., Ltd.
Representatives
Timothy T. Wang NI WANG & MASSAND PLLC
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposes for the treatment of tumor or cancerinflammationdiabetesosteoporosisimmune diseasesdermal diseasescardiovascular diseasescentral nervous system diseasesrespiratory diseases and disordersgastrointestinal diseasesbacterial or fungal infection containing peptides; Pharmaceutical preparations for the treatment of tumor or cancerinflammationdiabetesosteoporosisimmune diseasesdermal diseasescardiovascular diseasescentral nervous system diseasesrespiratory diseases and disordersgastrointestinal diseasesbacterial or fungal infection containing peptides; Drugs for medical purposesdrugs for the treatment of tumor or cancerinflammationdiabetesosteoporosisimmune diseasesdermal diseasescardiovascular diseasescentral nervous system diseasesrespiratory diseases and disordersgastrointestinal diseasesbacterial or fungal infection containing peptides; Active synthetic peptides used for the prevention and treatment of tumor or cancerinflammationdiabetesosteoporosisimmune diseasesdermal diseasescardiovascular diseasescentral nervous system diseasesrespiratory diseases and disordersgastrointestinal diseasesbacterial or fungal infection; Nutritional supplements containing peptides; Veterinary preparationspain relief medication containing peptides; Veterinary preparations for treatment of intestinal bacteriaparasiteinfectious diseasesdigestive system diseaserespiratory diseasereproductive diseases containing peptides; Biological preparations for veterinary purposesfor domestic animals and livestock for the prevention and treatment of infectious diseasesbacterial infectionshypertensioncardiovascular diseaseurinary infectionsrenal diseasereproductive diseases containing peptides; Dietary supplements for animals containing peptides
Class 35
Advertising; Medical supplies retail store and wholesale distributorship services; Business management and organization consulting; Providing an online market of goods and services for buyers and sellers; Sales promotion for others; Import-export agencies; Retail store and wholesale distributorship services for pharmaceuticalveterinary and sanitary preparations and medical supplies; Systemization of information into computer databases; Drug retail store and wholesale distributorship services; Veterinary drug retail store and wholesale distributorship services
Publications
History of USPTO decisions and trademark events.
65 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
04/26/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/26/2025
ES8R
TEAS SECTION 8 RECEIVED
11/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/27/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/26/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/15/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/14/2019
IUAF
USE AMENDMENT FILED
01/24/2019
EISU
TEAS STATEMENT OF USE RECEIVED
01/24/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/25/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
11/13/2018
OP.T
OPPOSITION TERMINATED NO. 999999
11/13/2018
OP.D
OPPOSITION DISMISSED NO. 999999
11/13/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/30/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/30/2018
OP.I
OPPOSITION INSTITUTED NO. 999999
02/27/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/22/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2017
PUBO
PUBLISHED FOR OPPOSITION
10/31/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/26/2017
ALIE
ASSIGNED TO LIE
09/25/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/23/2017
GNRT
NON-FINAL ACTION E-MAILED
06/23/2017
CNRT
NON-FINAL ACTION WRITTEN
06/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/27/2017
GNRT
NON-FINAL ACTION E-MAILED
02/27/2017
CNRT
NON-FINAL ACTION WRITTEN
02/27/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/17/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/23/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/23/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/23/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/30/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/30/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/12/2016
GNFR
FINAL REFUSAL E-MAILED
10/12/2016
CNFR
FINAL REFUSAL WRITTEN
10/12/2016
DOCK
ASSIGNED TO EXAMINER
09/14/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/14/2016
GNRT
NON-FINAL ACTION E-MAILED
03/14/2016
CNRT
NON-FINAL ACTION WRITTEN
03/14/2016
DOCK
ASSIGNED TO EXAMINER
03/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/21/2015
NWAP
NEW APPLICATION ENTERED
11/20/2015
Continuous trademark protection
Get notified about every new filing that threatens JYMED PEPTIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.